Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University, School of Medicine, Tokyo, Japan.
Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University, School of Medicine, Tokyo, Japan.
Allergol Int. 2017 Oct;66(4):568-573. doi: 10.1016/j.alit.2017.02.013. Epub 2017 Mar 17.
To avoid future risk is a definitive goal of long-term asthma management. Exacerbations are considered to be the most relevant future risk in real life asthma management. Few comparative studies have evaluated the risk factors associated with exacerbations in Japanese patients with asthma.
We performed the prospective 1-year follow up study in Japanese patients with adult asthma. A total of 189 patients with asthma were enrolled and followed up for 1 year. Finally, 181 patients completed the study protocol.
Of 181 patients, 43 patients (23.8%) had exacerbations during the follow-up period. Among the 45 patients who had exacerbations during the preceding year, 32 patients (71.1%) had exacerbations. Prevalence of patients with previous exacerbations and those with previous admissions were significantly higher in patients with exacerbations than those with no exacerbation. Logistic regression analysis also identified a significant association between exacerbations during the follow-up period and exacerbations during the preceding year, admissions during the preceding 3 years, ACT score below 20, low %FVC (<80%), or low FEV (<70%), respectively. Of the 55 patients with severe asthma, 29 patients (52.7%) had exacerbations. Among the 36 patients with severe asthma with previous exacerbations, 26 patients (72.2%) had exacerbations. The history of exacerbations during the preceding year was associated with a significantly increased risk of exacerbations both among the patients with severe asthma and those with non-severe asthma.
This study implicated that exacerbations during the preceding year reliably predict future risk of exacerbations in Japanese patients with asthma.
避免未来的风险是长期哮喘管理的明确目标。在现实生活中的哮喘管理中,加重被认为是最相关的未来风险。很少有比较研究评估过与日本哮喘患者加重相关的危险因素。
我们对日本成年哮喘患者进行了为期 1 年的前瞻性随访研究。共纳入 189 例哮喘患者,并随访 1 年。最终,181 例患者完成了研究方案。
在 181 例患者中,43 例(23.8%)在随访期间发生了加重。在过去 1 年中发生加重的 45 例患者中,32 例(71.1%)发生了加重。在有加重史和有住院史的患者中,发生加重的患者比例明显高于无加重的患者。Logistic 回归分析还表明,在随访期间发生加重与前一年发生加重、前 3 年住院、ACT 评分<20、%FVC<80%或 FEV<70%分别存在显著相关性。在 55 例重度哮喘患者中,29 例(52.7%)发生了加重。在有前一年加重史的 36 例重度哮喘患者中,26 例(72.2%)发生了加重。前一年加重史与重度和非重度哮喘患者的加重风险显著增加相关。
本研究表明,前一年的加重能够可靠地预测日本哮喘患者未来发生加重的风险。